Dr Richard Kim Joins the Healthily Board

Dr Richard Kim, an internationally renowned physician executive specialising in global healthcare strategy and digital health, is the latest medical specialist to join the Clinical Advisory Board at Healthily, the consumer digital healthcare company with one of the world’s leading artificial intelligence (AI) symptom checkers.

A US-based leader in employer wellbeing strategy and designing solutions for the next generation of healthcare delivery, Dr Kim most recently served as Chief Medical Officer at American Express. Here he led global health and safety programmes, and managed legal and labour complexities related to local government health and welfare requirements in Europe, Asia and the Americas.

During the COVID-19 pandemic, Dr Kim developed health and safety protocols and policies to protect Amex employees and customers, while maintaining business operations that yielded historic quarterly revenues. He also designed customer and employee safety policies for the US Open Tennis tournament, Wimbledon and the London Film Festival.

Prior to this, Dr Kim served as Associate Medical Director at Goldman Sachs, Executive Director at New York-Presbyterian Hospital in New York City and Medical Director at The Coca-Cola Company through Emory Healthcare.

Formerly Assistant Professor at Emory University, Dr Kim practised medicine at Eagle Hospital Physicians in Atlanta and Healthcare Partners in Los Angeles. He holds an MD from the Emory University School of Medicine, an MBA in strategy and business development from the Goizueta Business School at Emory University and a BA in Microbiology from Miami University.

A partnership in safety

With safety at the heart of everything it does, Healthily is delighted that Dr Kim’s wealth of experience will now be employed to assist its Clinical Advisory Board (CAB), a group of independent medical experts that ensures Healthily products and services meet the highest possible clinical standards.

Healthily was the first company to create an AI self-assessment tool with a CAB to independently scrutinise its clinical quality and efficacy. With the help of the CAB and an expert in-house medical team, Healthily became one of the first self-care apps to be self-certified as a Class I medical device in the EU and obtained the CE mark – indicating it complies with applicable EU directives and regulations and meets specific standards of performance, quality, safety and efficacy.

Dr Kim will serve on the board with chairperson Dr Mark Davies, Chief Medical Officer of IBM (EMEA), IBM Watson and formerly National Clinical Director for the NHS, alongside other renowned medical leaders. He will advise Healthily on strategy and business development with US healthcare providers and payers.

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."